Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-24 @ 11:57 PM
NCT ID:
NCT00924651
Eligibility Criteria:
Inclusion criteria:
* primary diagnosis of cancer other than leukemia, with no distant metastasis
* chemotherapy naïve
* starting chemotherapy treatments for cancer and scheduled for at least 6 weeks of treatments with treatment cycles of either 2, 3 or 4 weeks. Oral chemotherapy (e.g., Xeloda) is acceptable
* Karnofsky Performance level of 70 or greater
* able to read English
Exclusion criteria:
* diagnosis of leukemia
* metastatic disease
* receiving concurrent radiation therapy
* physical limitations (e.g., cardiorespiratory, orthopedic, central nervous system) that contraindicate participation in a low to moderate intensity home-based walking and progressive resistance program
* identified as in the active or maintenance stage of exercise behavior as assessed by the Exercise Stages of Change Short Form
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
120 Years
Study:
NCT00924651
Study Brief:
Protocol Section:
NCT00924651